Search academic texts

Information × Registration Number 0303U007657, 0103U008747 , R & D reports Title A controlled, randomized, phase III, multicenter open label study of AB1-007 (a Cremophor-Free, protein stabilized, Nanoparticle Paclitaxel) and Taxol in patients with metastatic breast cancer popup.stage_title Багатоцентрове рандомізоване відкрите порівняльне дослідження 3 фази препарату АВI-007 (нанодисперсний Паклитаксел, стабілізований білком, без носія Кремофор) і Таксолу при поширеному раці грудної залози Head Pilipenko M.I., Registration Date 18-11-2003 Organization Grigor'ev Institut for Medical Radiology popup.description2 Object of the research: women over 18 with metastatic breast cancer with quality of life index (ECOG) >2. Purpose of the research: to compare the efficacy of a new drug ABI-007 and Taxol according to survival, disease-free survival and quality of life. Methods of the research and equipment: clinical observations, radiology assessment of the dynamics of the tumor regression, biochemical and clinical laboratory tests (CT scanner, laboratory analyzers). Results and their novelty: new information can be obtained when studying a new effective antitumor drug. Area of application: oncology hospitals. Product Description popup.authors popup.nrat_date 2020-04-02 Close